Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
03/05/2025
ExxonMobil: We would do this if we could increase the net present value (NPV) of our investment by reserving opportunities (for future development).
Latest
10 m ago
UBS: Maintains rating for Church & Dwight Co (CHD.US) at Neutral, with target price adjusted from $110.00 to $102.00.
11 m ago
UBS: Maintains Builders FirstSource (BLDR.US) rating, adjusted from buy to buy rating, target price adjusted from $180.00 to $163.00.
13 m ago
UBS: Maintains a rating of Buy for Air Products & Chemicals (APD.US), with a target price adjusted from $335.00 to $324.00.
14 m ago
UBS: Maintains a buy rating on Bio-Rad Laboratories (BIO.US), revised from a buy to a buy rating. The target price has been adjusted from $355.00 to $310.00.
15 m ago
UBS: Maintains Amgen (AMGN.US) rating, adjusted from neutral to neutral, with a target price adjusted from $319.00 to $315.00.
See all latest